Phio Pharmaceuticals Corp. (NASDAQ:PHIO) currently has a daily average trading volume of 553.15K but it saw 1404621 shares traded on Wednesday. With a market cap of 7.42M USD, stock’s current market price of $4.24 came falling about -2.30 while comparing to the previous closing price of $4.34. In past 52 weeks, the stock remained buoying in the range of price level as high as $12.27 and as low as $3.11. In the recent trading on the day, stock has struck highest price mark of $5.29 while lowest mark touched by it was $4.01.
25-cent Stock Takes $11T Commodities Sector Digital
One brilliantly-run technology firm has successfully partnered with some of the largest players in the industry to bring a first-of-its-kind digital solution to the global commodities supply chain sector. Best of all, this upstart technology firm is currently trading undiscovered — below 25-cents per share — so very, very few investors know about it yet! For investors… it's an early-stage opportunity in a company that's bringing the US$11T global commodities sector straight into the 21st century.
All the details are in the FREE online report you can get here.
Taking a look at 20-day trading activity of Phio Pharmaceuticals Corp. (PHIO) gives us an average price of $3.97, while its current price level is -65.44% below from 52-week high level whereas it is 36.33% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $4.72 while that of 200 days or SMA-200 reads an average of $6.00. A closer look into the stock’s movement over the week reveals that its volatility is standing at 30.39% during that period while stretching the period over a month that decreases to 14.39%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 49.91 which implies that the stock is in neutral territory.
Phio Pharmaceuticals Corp. (PHIO)’s stock is currently under the radar of 1 analysts who are in consensus at a 12-month price target range of between $72.00 and $72.00 for company’s shares. The average price target assigned by the average number of analysts to a stock is a way to gauge worth of any stock in next 52 weeks. And in assigning price target to a stock, some analysts adopt a bearish approach by advocating lower-than-average price target which in this case is $72.00 while some adopt bullish approach by assigning higher-than-average price target which reads the price to top $72.00. Average price target assigned by them is $72.00 which highlights an upside potential of 94.11% for the stock over that period. And to attain the median price target of $72.00 assigned by those analysts, stock has to add about 94.11% of value to its current levels.
Data by FactSet Research shows that 1 analysts have issued their ratings for the stock. 0 of them are in opinions that stock is a Sell, while 0 are advising it as an Overweight. 1 analysts suggested the investors to Buy the stock while 0 advised them to Hold.
Over the week, PHIO’s stock price is moving 12.77% up while it is 26.57% when we observe its performance for the past one month. Year-to-date it is -5.02% down and over the past year, the stock is showing a downside performance of -48.12%.
The latest quarterly earnings report issued by the company was for quarter ended 12/30/2022, when its quarterly earnings per share (EPS) of -$2.4 beat the consensus estimate of -$3.24 for the same. The company is expected to be releasing its next quarterly report in 08/15/2023, for which analysts forecasted an EPS of $0 while estimate for next year EPS is $19.68.
Currently, Phio Pharmaceuticals Corp.’s total number of outstanding shares is 1.14M with 1.19% of that held by the insiders while 3.19% of its common stock has been owned by the institutions. Company’s return on equity (ROE) at -102.20%. Stock’s beta reads 1.44. Stock has a price to book (P/B) ratio of 0.66. Its return on asset (ROA) is -85.10% on average.
Leave a Reply